Cite
HARVARD Citation
Sun, T. et al. (2020). Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling. Molecular and cellular probes. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sun, T. et al. (2020). Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling. Molecular and cellular probes. p. . [Online].